Related Experiment Video
Updated: Jul 11, 2025

Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Bacteriophage Virus-Like Particles: Platforms for Vaccine Design
1School of Veterinary Medicine, Texas Tech University, Amarillo, TX, USA. etumban@ttu.edu.
Bacteriophage virus-like particles (VLPs) offer a cost-effective platform for developing novel vaccines. Their inherent immunogenicity in humans makes them promising for combating infectious and noninfectious diseases.
Area of Science:
- Biomedical Sciences
- Vaccinology
- Microbiology
Background:
- Bacteriophage virus-like particles (VLPs) are increasingly utilized in vaccine development.
- Traditional eukaryotic expression systems face limitations in cost and scalability for VLP production.
- The absence of pre-existing human antibodies against bacteriophage VLPs enhances antigen immunogenicity.
Approach:
- This review summarizes data on bacteriophage-based VLP peptide vaccines.
- It highlights strategies employed in developing these candidate vaccines.
- Focuses on VLPs derived from bacteriophages such as MS2, PP7, Qβ, AP205, and P22.
Key Points:
- Bacteriophage VLPs provide a scalable and economical alternative for vaccine manufacturing.
- Antigens displayed on bacteriophage VLP platforms exhibit high immunogenicity due to a lack of prior immune exposure.
- These VLP platforms are versatile for developing vaccines against both infectious and noninfectious agents.
Conclusions:
- Bacteriophage-derived VLPs represent a promising strategy for next-generation vaccine development.
- Their cost-effectiveness and immunogenic properties make them suitable for addressing global health challenges.
- Further research into VLP-based vaccine strategies can accelerate the development of effective disease preventatives.
More Related Videos
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Related Concept Videos
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Viral Structure
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Viral Replication: Lysogenic Cycle